Found: 234
Select item for more details and to access through your institution.
Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post‐marketing surveillance study.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 7, p. 950, doi. 10.1111/1346-8138.17270
- By:
- Publication type:
- Article
Total eosinophil count as a biomarker for therapeutic effects of upadacitinib in atopic dermatitis over 48 weeks.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1365544
- By:
- Publication type:
- Article
Real‐world effectiveness and safety of bimekizumab in Japanese patients with psoriasis: A single‐center retrospective study.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 5, p. 649, doi. 10.1111/1346-8138.17186
- By:
- Publication type:
- Article
Narrow Histopathological Margins are Acceptable in Surgical Resection of Basal Cell Carcinoma in Japanese: A Single-Center Retrospective Study.
- Published in:
- Journal of Nippon Medical School, 2024, v. 91, n. 3, p. 296, doi. 10.1272/jnms.JNMS.2024_91-308
- By:
- Publication type:
- Article
Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan.
- Published in:
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 261, doi. 10.1007/s40261-024-01352-4
- By:
- Publication type:
- Article
Dietary habits in adult Japanese patients with vitiligo.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 4, p. 491, doi. 10.1111/1346-8138.17163
- By:
- Publication type:
- Article
Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 4, p. 519, doi. 10.3390/ph17040519
- By:
- Publication type:
- Article
Epidermal turnover and iron metabolism in senile lentigo.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 3, p. 453, doi. 10.1111/1346-8138.17034
- By:
- Publication type:
- Article
Improvement of the head and neck regions with continuous tralokinumab treatment for up to 4 years in adults with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii49, doi. 10.1093/bjd/ljad498.051
- By:
- Publication type:
- Article
Correlation Analysis of Clinician- and Patient-Reported Outcomes Among Japanese Adults with Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 2, p. 533, doi. 10.1007/s13555-023-01094-9
- By:
- Publication type:
- Article
Pediatric psoriasis: Understanding pathological conditions and advances in treatment.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 2, p. 185, doi. 10.1111/1346-8138.17049
- By:
- Publication type:
- Article
Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: Analysis of the 3-Year Phase 3 Rising Up Study.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 1, p. 213, doi. 10.1007/s13555-023-01071-2
- By:
- Publication type:
- Article
Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with moderate‐to‐severe atopic dermatitis.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 12, p. 1576, doi. 10.1111/1346-8138.16950
- By:
- Publication type:
- Article
Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Clinical, Cosmetic & Investigational Dermatology, 2023, v. 16, p. 3201, doi. 10.2147/CCID.S439053
- By:
- Publication type:
- Article
Active Tuberculosis in a Patient Receiving Adalimumab for Psoriatic Arthritis and Chemoprophylaxis for Latent Tuberculosis Infection.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Background factors predicting the occurrence of herpes zoster in atopic dermatitis patients treated with upadacitinib.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 10, p. 1301, doi. 10.1111/1346-8138.16879
- By:
- Publication type:
- Article
English version of Japanese guidance for biologics in treating atopic dermatitis.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 10, p. e311, doi. 10.1111/1346-8138.16932
- By:
- Publication type:
- Article
Two cases of generalized pustular psoriasis successfully treated with bimekizumab.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 10, p. e357, doi. 10.1111/1346-8138.16866
- By:
- Publication type:
- Article
Dietary Fiber Inulin Improves Murine Imiquimod-Induced Psoriasis-like Dermatitis.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 18, p. 14197, doi. 10.3390/ijms241814197
- By:
- Publication type:
- Article
The disease burden of pediatric patients with atopic dermatitis in Japan.
- Published in:
- Pediatric Dermatology, 2023, v. 40, n. 5, p. 851, doi. 10.1111/pde.15399
- By:
- Publication type:
- Article
Efficacy and safety of baricitinib treatment for moderate to severe atopic dermatitis in real‐world practice in Japan.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 7, p. 869, doi. 10.1111/1346-8138.16763
- By:
- Publication type:
- Article
Recurrence or de novo? Intradermal Basal Cell Carcinoma of the Scrotum: A Report of Two Cases.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Safety and effectiveness of dupilumab in the real‐world treatment of atopic dermatitis in Japan: 1‐year interim analysis from a post‐marketing surveillance.
- Published in:
- Journal of Cutaneous Immunology & Allergy, 2023, v. 6, n. 3, p. 78, doi. 10.1002/cia2.12303
- By:
- Publication type:
- Article
English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 5, p. e138, doi. 10.1111/1346-8138.16797
- By:
- Publication type:
- Article
Impact of the Family and Household Environment on Pediatric Atopic Dermatitis in Japan.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 8, p. 2988, doi. 10.3390/jcm12082988
- By:
- Publication type:
- Article
Effectiveness of brodalumab in improving itching and skin pain in Japanese patients with psoriasis: The ProLOGUE study.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 4, p. 453, doi. 10.1111/1346-8138.16682
- By:
- Publication type:
- Article
The Eosinophil-to-Lymphocyte Ratio Acts as an Indicator for Improvement of Clinical Signs and Itch by Upadacitinib Treatment in Atopic Dermatitis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 6, p. 2201, doi. 10.3390/jcm12062201
- By:
- Publication type:
- Article
Effects of Biologic Therapy on Laboratory Indicators of Cardiometabolic Diseases in Patients with Psoriasis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 1934, doi. 10.3390/jcm12051934
- By:
- Publication type:
- Article
Change in Serum KL-6 Level during Biologic Treatment for Psoriasis.
- Published in:
- Journal of Nippon Medical School, 2023, v. 90, n. 2, p. 194, doi. 10.1272/jnms.JNMS.2023_90-207
- By:
- Publication type:
- Article
Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study.
- Published in:
- Patient Preference & Adherence, 2023, v. 17, p. 861, doi. 10.2147/PPA.S389865
- By:
- Publication type:
- Article
309 Tralokinumab demonstrated a consistent safety profile with up to 42 months of treatment in moderate-to-severe atopic dermatitis: including adverse events of special interest.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. ii6, doi. 10.1093/bjd/ljac140.009
- By:
- Publication type:
- Article
Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B‐PAD study).
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 2, p. 233, doi. 10.1111/cea.14267
- By:
- Publication type:
- Article
Biomarkers and Predictive Factors for Treatment Response to Tumor Necrosis Factor-α Inhibitors in Patients with Psoriasis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 974, doi. 10.3390/jcm12030974
- By:
- Publication type:
- Article
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version).
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 2, p. e41, doi. 10.1111/1346-8138.16691
- By:
- Publication type:
- Article
Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: 2-Year Interim Results from the Phase 3 Rising Up Study.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 1, p. 221, doi. 10.1007/s13555-022-00842-7
- By:
- Publication type:
- Article
English version of Japanese guidance for the use of oral Janus kinase (JAK) inhibitors in the treatments of atopic dermatitis.
- Published in:
- Journal of Dermatology, 2023, v. 50, n. 1, p. e1, doi. 10.1111/1346-8138.16635
- By:
- Publication type:
- Article
Change in Antinuclear Antibody Titers during Biologic Treatment for Psoriasis.
- Published in:
- Journal of Nippon Medical School, 2023, v. 90, n. 1, p. 96, doi. 10.1272/jnms.JNMS.2023_90-115
- By:
- Publication type:
- Article
THE BRIEF COMMENTARY ON GUIDELINES FORTHE MANAGEMENT OF ATOPIC DERMATITIS 2021 --THE POINT OF DRUG TREATMENT--.
- Published in:
- Arerugi: Japanese Journal of Allergology, 2022, v. 71, n. 10, p. 1201
- By:
- Publication type:
- Article
Pooled Safety Analysis of Baricitinib in Adult Participants with Atopic Dermatitis in the Japanese Subpopulation from Six Randomized Clinical Trials.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 12, p. 2765, doi. 10.1007/s13555-022-00828-5
- By:
- Publication type:
- Article
Nephritis-associated plasmin receptor (NAPlr) in streptococcal infection associated cutaneous IgA vasculitis.
- Published in:
- Clinical & Experimental Nephrology, 2022, v. 26, n. 11, p. 1146, doi. 10.1007/s10157-022-02251-8
- By:
- Publication type:
- Article
Proactive versus Rank-Down Topical Corticosteroid Therapy for Maintenance of Remission in Pediatric Atopic Dermatitis: A Randomized, Open-Label, Active-Controlled, Parallel-Group Study (Anticipate Study).
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 21, p. 6477, doi. 10.3390/jcm11216477
- By:
- Publication type:
- Article
The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real‐world practice in Japan.
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 11, p. 1158, doi. 10.1111/1346-8138.16549
- By:
- Publication type:
- Article
Association of Transition of Laboratory Markers with Transition of Disease Activity in Psoriasis Patients Treated with Biologics.
- Published in:
- Journal of Nippon Medical School, 2022, v. 89, n. 6, p. 587, doi. 10.1272/jnms.JNMS.2022_89-613
- By:
- Publication type:
- Article
Molecular Mechanisms and Targeted Therapies of Advanced Basal Cell Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11968, doi. 10.3390/ijms231911968
- By:
- Publication type:
- Article
Work productivity in real‐life employed patients with plaque psoriasis: Results from the ProLOGUE study.
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 10, p. 970, doi. 10.1111/1346-8138.16517
- By:
- Publication type:
- Article
English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021.
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 10, p. e315, doi. 10.1111/1346-8138.16527
- By:
- Publication type:
- Article
Evaluation of standard treatments for managing adult Japanese patients with inadequately controlled moderate‐to‐severe atopic dermatitis: Two‐year data from the ADDRESS‐J disease registry.
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 9, p. 903, doi. 10.1111/1346-8138.16485
- By:
- Publication type:
- Article
Maculopapular Drug Eruption Caused by Apalutamide: Case Report and Review of the Literature.
- Published in:
- Journal of Nippon Medical School, 2022, v. 89, n. 5, p. 550, doi. 10.1272/jnms.JNMS.2022_89-503
- By:
- Publication type:
- Article
Difamilast Ointment in Japanese Adult and Pediatric Patients with Atopic Dermatitis: A Phase III, Long-Term, Open-Label Study.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 7, p. 1589, doi. 10.1007/s13555-022-00751-9
- By:
- Publication type:
- Article
Two novel mutations in the ATP2C1 gene found in Japanese patients with Hailey–Hailey disease.
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 6, p. 656, doi. 10.1111/1346-8138.16353
- By:
- Publication type:
- Article